Biological Standardization of Platanus Acerifolia Allergen Extract
NCT01739322 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2018-02-23
Summary
The objective of this study is to determine the biologic activity of a Platanus acerifolia allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).
Conditions
- Allergy to Platanus Acerifolia
Interventions
- BIOLOGICAL
-
Prick test Platanus acerifolia allergen extract
This is an open, unblinded and non randomized biological as proposed by the Nordic Guidelines. Four concentrations of Platanus acerifolia allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm. This test will be referred to as the Titrated Skin Prick test.
Sponsors & Collaborators
-
Laboratorios Leti, S.L.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- Spain
Study Locations
More Related Trials
-
To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.
NCT01984541 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)
NCT02512653 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Dactylis Glomerata Allergen Extract
NCT01407835 ·Status: COMPLETED ·Phase: PHASE2
-
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.
NCT05533385 ·Status: COMPLETED ·Phase: NA
-
Biological Standardization of Poa Pratensis Allergen Extract
NCT01430117 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Secale Cereale Allergen Extract
NCT01408238 ·Status: COMPLETED ·Phase: PHASE2
-
Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).
NCT00917488 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa
NCT02527187 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of Biological Activity of Three Allergen Extracts
NCT02474836 ·Status: COMPLETED ·Phase: PHASE2
-
To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.
NCT01984528 ·Status: COMPLETED ·Phase: PHASE2
-
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization
NCT06957496 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis
NCT02126111 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)
NCT00537342 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus
NCT01147159 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts
NCT01567319 ·Status: COMPLETED ·Phase: PHASE1
-
Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
NCT01719133 ·Status: COMPLETED ·Phase: PHASE1
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
NCT00916422 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability of ALK Tree Tablet
NCT00535639 ·Status: COMPLETED ·Phase: PHASE1
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen
NCT00831025 ·Status: COMPLETED ·Phase: PHASE3
-
This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
NCT03926611 ·Status: COMPLETED ·Phase: PHASE2
-
Comparability and Standardization of Controlled Allergen Challenge Facilities
NCT02543346 ·Status: COMPLETED ·Phase: PHASE4
-
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
NCT01241214 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense
NCT00501527 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
NCT01484119 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria
NCT00421109 ·Status: COMPLETED ·Phase: PHASE3